Abstract
Background
A case-control study was performed to examine age, gender, and ABO blood groups in 1014 Iraqi hospitalized cases with Coronavirus disease 2019 (COVID-19) and 901 blood donors (control group). The infection was molecularly diagnosed by detecting coronavirus RNA in nasal swabs of patients.
Results
Mean age was significantly elevated in cases compared to controls (48.2 ± 13.8 vs. 29.9 ± 9.0 year; probability [p] < 0.001). Receiver operating characteristic analysis demonstrated the predictive significance of age in COVID-19 evolution (Area under curve = 0.858; 95% CI: 0.841 – 0.875; p < 0.001). Males outnumbered females in cases (60.4 vs. 39.6%) and controls (56 vs. 44%). Stratification by age group (< 30, 30 – 39, 40 – 49 and ≥ 50 years) revealed that 48.3% of cases clustered in the age group ≥ 50 years. ABO blood group analysis showed that group A was the most common among cases, while group O was the most common among controls (35.5 and 36.7%, respectively). Blood groups A (35.5 vs. 32.7; corrected p [pc] = 0.021), A+AB (46.3 vs. 41.7%; pc = 0.021) and A+B+AB (68.0 vs. 63.3%; pc = 0.007) showed significantly elevated frequencies in cases compared to controls. Logistic regression analysis estimated odds ratios (ORs) of 1.53 (95% confidence interval [CI]: 1.16 - 2.02), 1.48 (95% CI: 1.14 - 1.93) and 1.50 (95% CI: 1.17 - 1.82) for blood groups A, A+AB and A+B+AB, respectively. Blood group frequencies showed no significant differences between age groups of cases or controls. Regarding gender, male cases were marked with increased frequency of group A (39.9 vs. 28.9%) and decreased frequency of group O (25.9 vs. 41.0%) compared to female cases. Independent re-analysis of ABO blood groups in male and female cases demonstrated that group A was increased in male cases compared to male controls (39.9 vs. 33.1%; OR = 1.65; 95% CI: 1.24 - 2.21; pc = 0.006). On the contrary, no significant differences were found between females of cases and controls.
Conclusions
The study results indicated that blood group A may be associated with an increased risk of developing COVID-19, particularly in males.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Abdullah, Maha H. 2 ; Alsudani, Mustafa Y. 3 ; Shnawa, Rasool M. S. 4 ; Al-Sa’ady, Ali J. R. 5 ; Allami, Risala H. 2 ; Misha’al, Khawla I. 1 ; Jassim, Iftikhar A. 1 ; Taqi, Estabraq A. 1 1 University of Baghdad, Tropical-Biological Research Unit, College of Science, Baghdad, Iraq (GRID:grid.411498.1) (ISNI:0000 0001 2108 8169)
2 Al-Nahrain University, College of Biotechnology, Baghdad, Iraq (GRID:grid.411310.6) (ISNI:0000 0004 0636 1464)
3 Ministry of Health and Environment, Basrah Health Office, Basrah, Baghdad, Iraq (GRID:grid.415808.0) (ISNI:0000 0004 1765 5302)
4 Ministry of Health and Environment, Alforat Hospital, Baghdad, Baghdad, Iraq (GRID:grid.415808.0) (ISNI:0000 0004 1765 5302)
5 University of Baghdad, Biotechnology Department, College of Science, Baghdad, Iraq (GRID:grid.411498.1) (ISNI:0000 0001 2108 8169)





